Latest Content

MASLD was linked to higher odds of EoE and reflux-related diseases, suggesting metabolic dysfunction may contribute to esophageal disease.

Remote monitoring with tailored texts improved endocrine therapy adherence among breast cancer survivors with low symptom-management self-efficacy, with benefits becoming nonsignificant at higher self-efficacy levels.

Moderna’s mRNA flu vaccine receives FDA approval after phase 3 data showed improved efficacy compared with standard flu vaccines.

Health plans can use routine pharmacy claims to identify members at high risk for early discontinuation of glucagon-like peptide-1 receptor agonists and deliver targeted, equity-conscious adherence support.

CANN says the revised pilot reflects stakeholder input and aims to address accountability challenges in the more than $100 billion 340B program.

Higher CCI scores, prior infection, and prior prophylactic anti-infective treatment were associated with greater risk of subsequent infection in both cancers.

Lilly opens early access to retatrutide for some patients before FDA approval, following scrutiny over a single earlier compassionate-use case.

The former deputy surgeon general takes over an agency that has lacked permanent leadership since Susan Monarez, PhD, was ousted.

A review argues lung cancer screening should move beyond smoking history to include environmental exposures, family history, and AI-driven risk models.